Toso inhibitors belong to a specific category of chemical compounds designed to target and inhibit the activity of the Toso protein, also known as Fas apoptotic inhibitory molecule 3 (FAIM3). Toso is a transmembrane protein expressed in various immune cells, particularly B cells, and it plays a significant role in modulating immune responses, particularly those involving B cell activation and apoptosis regulation. Toso functions as a negative regulator of Fas-mediated apoptosis, a critical pathway in immune cell regulation. Fas, also known as CD95, is a cell surface receptor that can trigger programmed cell death (apoptosis) in response to specific signals. Toso inhibits the activation of Fas by preventing its clustering and downstream signaling, thereby promoting the survival of immune cells and potentially influencing immune homeostasis. Inhibitors of Toso are primarily developed for research purposes, serving as essential tools for scientists and researchers to investigate the molecular mechanisms and functions associated with this protein in the context of immune regulation and cellular biology.
Toso inhibitors are typically composed of small molecules or chemical compounds specifically designed to interact with the Toso protein, disrupting its normal function in regulating Fas-mediated apoptosis. By inhibiting Toso, these compounds can potentially interfere with the ability of Toso to inhibit Fas activation, leading to alterations in apoptotic signaling in immune cells. Researchers use Toso inhibitors in laboratory settings to manipulate the activity of this protein and study its roles in various immune responses, particularly those related to B cell survival and immune cell regulation. These inhibitors provide valuable insights into the molecular mechanisms by which Toso influences immune cell survival and contribute to a deeper understanding of its significance in the context of cellular and immune system biology. While Toso inhibitors may have broader implications, their primary purpose is to assist scientists in deciphering the intricacies of Toso-mediated immune regulation.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As a histone deacetylase inhibitor, it may change chromatin structure and potentially decrease Toso transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could lead to hypomethylation and altered gene expression, possibly affecting Toso expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
By inhibiting histone deacetylases, it could alter gene expression patterns, possibly influencing Toso levels. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Similar to 5-Azacytidine, it could affect DNA methylation and potentially modulate Toso gene expression. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
A PARP inhibitor that may indirectly affect transcription processes, potentially impacting Toso expression. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
As an MDM2 antagonist, it could modulate p53-dependent gene expression, potentially altering Toso levels. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
A cyclin-dependent kinase inhibitor that may influence cell cycle-related gene expression, possibly affecting Toso expression. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
Known as palbociclib, it inhibits CDK4/6 and may change the transcriptional profile of cells, potentially influencing Toso expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Also a proteasome inhibitor, it could affect NF-κB signaling and potentially alter Toso expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
Inhibits BET bromodomain proteins, potentially affecting transcription and possibly decreasing Toso expression. |